Pay in 4 interest-free payments of $5.71 Learn more
Ships within 48 hours · Estimated delivery Aug 30 - Sep 4
(The Endocrine Society) Product information checked: July 28, 2026 Affiliate Disclosure: This page may contain affiliate links
Complete Certifications: The factory has achieved a number of certifications, including cGMP, ISO22000, ISO14001, ISO9001, HOSHER, and HALAL, demonstrating full compliance with worldwide market standards
2.4% placebo in STEP-1 (N=1,961) Compounding context / FDA has permitted compounding of certain GLP-1 drugs during shortage periods under 503A/503B pathways HRT candidate profile / symptomatic peri- or postmenopausal women, or men with confirmed hypogonadism (total testosterone below 300 ng/dL on two morning draws) Cost structure / cash-pay
DOI: 10.1177/0194599813492644
Semaglutide works only on the GLP-1 pathway, while Tirzepatide targets both GLP-1 and GIP pathways, often leading to greater weight loss
US$ 28.39
US$ 28.93
US$ 26.46
US$ 23.10
US$ 20.09
US$ 29.24
US$ 28.99
US$ 28.02
US$ 22.08
US$ 20.19
US$ 28.70
